A detailed history of Auour Investments LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Auour Investments LLC holds 17,000 shares of MCRB stock, worth $13,940. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,000
Previous 17,000 -0.0%
Holding current value
$13,940
Previous $12,000 33.33%
% of portfolio
0.01%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 07, 2023

BUY
$4.67 - $6.55 $79,390 - $111,350
17,000 New
17,000 $81.4 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Auour Investments LLC Portfolio

Follow Auour Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auour Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Auour Investments LLC with notifications on news.